To address this hypothesis, we inoculated WT and cKO mice with MC38 murine colon cancer cells subcutaneously to determine whether Ifitm3 is required for Treg cells in anti-tumor responses in vivo. This evidence concerns the gene IFITM3 and malignant colon neoplasm.